The Food and Drug Administration (FDA) is reportedly set to announce a warning for the Johnson & Johnson coronavirus vaccine saying it has been linked to a serious, although rare, side effect.
The side effect is known as Guillain-Barré syndrome (GBS), the Washington Post reported Monday:
About 100 preliminary reports of Guillain-Barré have been detected after the administration of 12.8 million doses of Johnson & Johnson vaccine in the United States, the Centers for Disease Control and Prevention said in a statement Monday. The cases have largely been reported about two weeks after vaccination and mostly in men, many aged 50 and older.
Available data do not show a pattern suggesting a similar increased risk with the Pfizer-BioNTech and Moderna vaccines, after more than 321 million doses of those vaccines have been administered in the United States.
According to the Centers for Disease Control and Prevention (CDC)